Callan Capital LLC Boosts Holdings in Genpact Limited (NYSE:G)

Callan Capital LLC grew its position in Genpact Limited (NYSE:GFree Report) by 9.6% in the fourth quarter, HoldingsChannel reports. The fund owned 11,961 shares of the business services provider’s stock after acquiring an additional 1,046 shares during the quarter. Callan Capital LLC’s holdings in Genpact were worth $514,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of G. JPMorgan Chase & Co. raised its position in shares of Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after acquiring an additional 2,060,595 shares during the period. Tandem Investment Advisors Inc. raised its position in shares of Genpact by 390.5% in the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock worth $91,480,000 after acquiring an additional 1,695,706 shares during the period. Los Angeles Capital Management LLC acquired a new position in shares of Genpact in the third quarter worth about $19,779,000. Geode Capital Management LLC raised its position in shares of Genpact by 12.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock worth $148,142,000 after purchasing an additional 413,646 shares during the last quarter. Finally, Empowered Funds LLC raised its position in shares of Genpact by 1,942.3% during the 4th quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider’s stock worth $13,975,000 after purchasing an additional 309,447 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.

Genpact Stock Down 2.3 %

G stock opened at $53.21 on Friday. The company has a market cap of $9.38 billion, a price-to-earnings ratio of 18.73, a PEG ratio of 1.84 and a beta of 1.20. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The firm has a 50-day moving average of $47.00 and a two-hundred day moving average of $42.81.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.28%. Genpact’s dividend payout ratio is 21.48%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on G. Mizuho upped their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Robert W. Baird upped their price target on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Genpact presently has an average rating of “Hold” and a consensus price target of $48.44.

Read Our Latest Stock Analysis on Genpact

Insider Activity

In other news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $12,407,545.60. This trade represents a 3.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 34,600 shares of company stock valued at $1,538,120 in the last 90 days. Company insiders own 2.80% of the company’s stock.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.